The demand for diagnostic services is being driven by lifestyle changes and increasing awareness of health-related issues, Sharma said. Since its IPO, shares of Dr Lal PathLabs have jumped almost 76% from its sale price of Rs.550. “As the economy grows and per capita income grows, healthcare awareness will grow further, which will drive preventive healthcare services such as diagnostics,” Sharma added. On Monday, Dr Lal Pathlabs Ltd closed at Rs.970.50 on BSE. The highly fragmented domestic diagnostic market has an estimated size of Rs.37,700 crore and stand-alone diagnostic centres hold about 48% of the market.

Source: Mint July 25, 2016 21:33 UTC